Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Janux Therapeutics (JANX) Return on Equity (2021 - 2025)

Historic Return on Equity for Janux Therapeutics (JANX) over the last 5 years, with Q3 2025 value amounting to 0.1%.

  • Janux Therapeutics' Return on Equity fell 100.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.1% for FY2024, which is 700.0% up from last year.
  • As of Q3 2025, Janux Therapeutics' Return on Equity stood at 0.1%, which was down 100.0% from 0.11% recorded in Q2 2025.
  • Over the past 5 years, Janux Therapeutics' Return on Equity peaked at 0.05% during Q3 2021, and registered a low of 0.22% during Q2 2023.
  • For the 5-year period, Janux Therapeutics' Return on Equity averaged around 0.13%, with its median value being 0.11% (2024).
  • In the last 5 years, Janux Therapeutics' Return on Equity crashed by -1200bps in 2022 and then surged by 1500bps in 2024.
  • Over the past 5 years, Janux Therapeutics' Return on Equity (Quarter) stood at 0.09% in 2021, then plummeted by -120bps to 0.19% in 2022, then increased by 13bps to 0.17% in 2023, then soared by 51bps to 0.08% in 2024, then decreased by -26bps to 0.1% in 2025.
  • Its Return on Equity stands at 0.1% for Q3 2025, versus 0.11% for Q2 2025 and 0.08% for Q1 2025.